Shionogi & Co., Ltd.

Shionogi & Co., Ltd.

SGIOF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$16.98B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Shionogi & Co., Ltd.Shionogi & Co., Ltd.11.22.46%14%-0.4

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$16.98 Billion
Enterprise Value$325.36 Billion
Annual dividend$0.49
Dividend yield2.46%
Earnings per Share$242.87
Beta0.03
Outstanding Shares851,520,000

Return

Return on Equity13.72%ROE
Return on Assets9.07%
Return on Invested Capital12.12%

Valuation & Multiples

P/E Ratio11.19P/E Ratio
PEG-22.08PEG
Price to Sales0.03Price to Sales
Price to Book Ratio0.01Price to Book Ratio
Enterprise Value to Revenue0.51
Enterprise Value to EBIT1.47
Enterprise Value to Net Income1
Total Debt to Enterprise2.11
Debt to Equity0.39Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
October 29, 2026
EPS
$0.16
Est. $0.28
Revenue
$1.19 B
Est. $1.12 B

Next Earnings Call

Expected Date
February 5, 2027
EPS Estimate
$0.41
Consensus analyst estimate
Revenue Estimate
$1.18 B
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Shionogi & Co., Ltd.

6,223 employees
CEO: Isao Teshirogi

Shionogi & Co., Ltd., an Osaka, Japan-based pharmaceutical company established in 1878, focuses on the discovery, development, production, and commercialization of medicines, diagnostic tools, and medical devices primarily within Japan. ...